Dennis Christensen | Head of Global R&D
Croda

Dennis Christensen, Head of Global R&D, Croda

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery systems. In this period, he has played a key role in the development of the CAF® adjuvant portfolio. His recent research includes designing vaccines that target specific subsets of APCs and direction of vaccine-induced immune responses to specific tissues. He is a key opinion leader in the vaccine adjuvant research field and has an extensive experience with international vaccine research collaborations and with coordinating the research work in such projects.

Appearances:



Pre-Congress Workshops - 21st April @ 14:00

VACCINE DELIVERY

Main Congress Day 2 - 23rd April @ 09:55

Driving vaccine adjuvants and delivery systems development to secure a sustainable supply

last published: 13/Mar/25 11:25 GMT

back to speakers